Intrauterine Drug Exposure
The AAP's Committee on Drugs statement includes information about the clinical presentation, differential diagnosis, therapeutic options, and outcome for offspring associated with intrauterine drug exposure.
This e-medicine article provides an organized source of information about medication use in pregnancy with data regarding commonly used medications and pregnancy categories established by the FDA.
A volumetric MRI study of the brain in children with intrauterine drug exposure from the AAP.
This AAP published article is an overview of the Infant Development, Environment, and Lifestyle Study addressing the effects of prenatal methanphetamine exposure, polydrug exposure, and poverty on intrauterine growth.
A technical report from the AAP about the effects of secondhand tobacco smoke.
The Stanford School of Medicine's video of a newborn patient presenting with abstinence syndrome resulting from prescription drug use by the mother during pregnancy.
The National Institute on Drug Abuse (NIDA) summary of research on the effects of prenatal drug exposure and drug-abusing environments including estimated social and economic impact.